These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17721920)

  • 1. Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous cell carcinoma.
    Patel H; Polanco-Echeverry G; Segditsas S; Volikos E; McCart A; Lai C; Guenther T; Zaitoun A; Sieber O; Ilyas M; Northover J; Silver A
    Int J Cancer; 2007 Dec; 121(12):2668-73. PubMed ID: 17721920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma.
    Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; French D; Limiti MR; Ghini C; Vecchione A
    J Exp Clin Cancer Res; 1999 Mar; 18(1):47-52. PubMed ID: 10374676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
    Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
    Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
    Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.
    Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR
    Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
    Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
    J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
    Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
    BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
    Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
    PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer.
    Macedo J; Silva E; Nogueira L; Coelho R; da Silva J; Dos Santos A; Teixeira-Júnior AA; Belfort M; Silva G; Khayat A; de Oliveira E; Dos Santos AP; Cavalli LR; Pereira SR
    Mol Carcinog; 2020 Jun; 59(6):604-617. PubMed ID: 32212199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
    Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
    Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis.
    Baricevic I; He X; Chakrabarty B; Oliver AW; Bailey C; Summers J; Hampson L; Hampson I; Gilbert DC; Renehan AG
    Eur J Cancer; 2015 Apr; 51(6):776-85. PubMed ID: 25702585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma.
    Takahashi K; Miyashita M; Makino H; Akagi I; Orita H; Hagiwara N; Nomura T; Gabrielson EW; Tajiri T
    Exp Mol Pathol; 2009 Aug; 87(1):42-7. PubMed ID: 19124015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Shigaki H; Baba Y; Watanabe M; Murata A; Ishimoto T; Iwatsuki M; Iwagami S; Nosho K; Baba H
    Clin Cancer Res; 2013 May; 19(9):2451-9. PubMed ID: 23532889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients.
    Laytragoon-Lewin N; Nilsson PJ; Castro J; Gharizadeh B; Nyren P; Glimelius B; Elmberger G; Turesson I; Svensson C
    Anticancer Res; 2007; 27(6C):4473-9. PubMed ID: 18214063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.